These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16289072)

  • 1. Myeloperoxidase genetic polymorphisms modulate human neutrophil enzyme activity: genetic determinants for atherosclerosis?
    Chevrier I; Tregouet DA; Massonnet-Castel S; Beaune P; Loriot MA
    Atherosclerosis; 2006 Sep; 188(1):150-4. PubMed ID: 16289072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloperoxidase: new polymorphisms and relation with lung cancer risk.
    Chevrier I; Stücker I; Houllier AM; Cenée S; Beaune P; Laurent-Puig P; Loriot MA
    Pharmacogenetics; 2003 Dec; 13(12):729-39. PubMed ID: 14646692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil myeloperoxidase activity and the influence of two single-nucleotide promoter polymorphisms.
    Rutgers A; Heeringa P; Giesen JE; Theunissen RT; Jacobs H; Tervaert JW
    Br J Haematol; 2003 Nov; 123(3):536-8. PubMed ID: 14617020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional polymorphism of the myeloperoxidase gene in hypertensive nephrosclerosis dialysis patients.
    Doi K; Noiri E; Maeda R; Nakao A; Kobayashi S; Tokunaga K; Fujita T
    Hypertens Res; 2007 Dec; 30(12):1193-8. PubMed ID: 18344624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The myeloperoxidase -463G/A polymorphism and coronary artery disease risk: A meta-analysis of 1938 cases and 1990 controls.
    Chang C; Gao B; Liu Z; Mao J; Jiang G
    Clin Biochem; 2013 Nov; 46(16-17):1644-8. PubMed ID: 24036021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between MPO 129 A/G polymorphism and severity of coronary artery disease].
    Hu JL; Xu JB; Zhou X; Jiang TM; Li YM; Zhang M
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2011 Aug; 27(3):306-10. PubMed ID: 22097722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between myeloperoxidase polymorphisms and its plasma levels with severity of coronary artery disease.
    Wainstein RV; Wainstein MV; Ribeiro JP; Dornelles LV; Tozzati P; Ashton-Prolla P; Ewald IP; Vietta G; Polanczyk CA
    Clin Biochem; 2010 Jan; 43(1-2):57-62. PubMed ID: 19651119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic polymorphisms of MPO, NQO1, GSTP1, UGT1A6 associated with susceptibility of chronic benzene poisoning].
    Sun P; Zhang Z; Wan J; Shao M
    Wei Sheng Yan Jiu; 2007 Jan; 36(1):11-5. PubMed ID: 17424838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of myeloperoxidase -463 G/A gene polymorphism and plasma levels on coronary artery disease.
    Ergen A; İsbir S; Timirci Ö; Tekeli A; İsbir T
    Mol Biol Rep; 2011 Feb; 38(2):887-91. PubMed ID: 20568015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No relationship between neutrophil granulocyte activation and the myeloperoxidase gene - 129 G>A and - 463 G>A promoter polymorphisms: implications for investigations of cardiovascular disease.
    Videm V; Olsen GD
    Coron Artery Dis; 2009 Nov; 20(7):446-52. PubMed ID: 19877306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of multiple single nucleotide polymorphisms (SNPs) of myeloperoxidase (MPO) to screen for genetic markers associated with acute leukemia in Chinese Han population.
    Zhang J; Zhu FY; Pu YP; Yin LH; Luo J; Wang WP; Zhou GH
    J Toxicol Environ Health A; 2007 Jun; 70(11):901-7. PubMed ID: 17479404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloperoxidase polymorphism and coronary artery disease risk: A meta-analysis.
    Wang Y; Chen XY; Wang K; Li S; Zhang XY
    Medicine (Baltimore); 2017 Jul; 96(27):e7280. PubMed ID: 28682877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms.
    Hoy A; Trégouët D; Leininger-Muller B; Poirier O; Maurice M; Sass C; Siest G; Tiret L; Visvikis S
    Eur J Hum Genet; 2001 Oct; 9(10):780-6. PubMed ID: 11781690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloperoxidase (MPO) -463G->A reduces MPO activity and DNA adduct levels in bronchoalveolar lavages of smokers.
    Van Schooten FJ; Boots AW; Knaapen AM; Godschalk RW; Maas LM; Borm PJ; Drent M; Jacobs JA
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):828-33. PubMed ID: 15159316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined polymorphisms in oxidative stress genes predict coronary artery disease and oxidative stress in coronary angiography patients.
    Heslop CL; Tebbutt SJ; Podder M; Ruan J; Hill JS
    Ann Hum Genet; 2012 Nov; 76(6):435-47. PubMed ID: 23003332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRISMA-combined Myeloperoxidase -463G/A gene polymorphism and coronary artery disease: A meta-analysis of 4744 subjects.
    Li YY; Wang H; Qian J; Kim HJ; Wu JJ; Wang LS; Zhou CW; Yang ZJ; Lu XZ
    Medicine (Baltimore); 2017 Mar; 96(12):e6461. PubMed ID: 28328864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma myeloperoxidase level and peripheral arterial disease.
    Haslacher H; Perkmann T; Gruenewald J; Exner M; Endler G; Scheichenberger V; Wagner O; Schillinger M
    Eur J Clin Invest; 2012 May; 42(5):463-9. PubMed ID: 21950958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloperoxidase -463G>A polymorphism and risk of primary lung cancer in a Korean population.
    Park JH; Park JM; Kim EJ; Cha SI; Lee EB; Kim CH; Kam S; Jung TH; Park JY
    Cancer Detect Prev; 2006; 30(3):257-61. PubMed ID: 16844322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of myeloperoxidase promoter polymorphism and long-term hormone replacement therapy to oxidized low-density lipoprotein autoantibodies in postmenopausal women.
    Mäkelä R; Dastidar P; Jokela H; Jaakkola O; Saarela M; Punnonen R; Lehtimäki T
    Scand J Clin Lab Invest; 2006; 66(5):371-83. PubMed ID: 16901848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of
    Arslan S; Berkan Ö; Bayyurt B; Beton O; Şahin NLÖL; Aydemir EI
    Biomed Rep; 2017 Dec; 7(6):547-552. PubMed ID: 29188060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.